An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates

In this case-based review of contemporary treatment for CLL, you will learn how to optimize patient outcomes through expert-informed strategies on selecting first-line and late-line therapy and managing treatment-related adverse events via downloadable slides and an expert-written ClinicalThought.

Share

Program Content

Activities

Frontline Therapy for CLL
Selecting Initial Therapy for Patients With CLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Treating Relapsed CLL
Considerations in Selecting Therapy for Previously Treated CLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Emerging Treatment Strategies in CLL
A Look to the Future: Novel Agents and Combination Regimens
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Faculty

cover img faculity

Danielle M. Brander, MD

Associate Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Department of Medicine, Duke University
Director, CLL/Lymphoma Research
Duke Cancer Institute
Durham, North Carolina

cover img faculity

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Sameer A. Parikh, MBBS

Consultant, Division of Hematology
Chair, CLL Disease Team
Vice Chair, Lymphoid Malignancies Disease Group
Mayo Clinic Comprehensive Cancer Center
Associate Professor of Medicine
Assistant Professor of Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, BeiGene, and Lilly.

AstraZeneca

BeiGene

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner